Veloxis Pharmaceuticals A/S (VELO) to Present Results from a Patient Subgroup Analysis of Once-Daily LCP-Tacro™ in Stable African-American Kidney Transplant Patients at American Transplant Congress
6/1/2012 9:42:44 AM
More...
|
Bristol-Myers Squibb Company (BMY) New Data on Investigational Agent Belatacept in Kidney Transplant Recipients to be Presented at 2011 American Transplant Congress
4/25/2011 8:30:27 AM
More...
|
REGiMMUNE Presents New ToleroVax Data at the 2010 American Transplant Congress
5/5/2010 11:19:23 AM
More...
|
Alexion Pharmaceuticals Inc. (ALXN) Research to be Presented at the American Transplant Congress Examines the Role of Terminal Complement Inhibition in the Treatment of Kidney Transplantation Patients
4/30/2010 9:17:51 AM
More...
|
REGiMMUNE to Present Data From Preclinical Study of RGI-2001 at the 2010 American Transplant Congress
4/28/2010 11:26:50 AM
More...
|
Bristol-Myers Squibb Company (BMY) Release: New Data on the Use of Investigational Agent Belatacept in Kidney Transplant Recipients to Be Presented at 2010 American Transplant Congress
4/28/2010 9:27:57 AM
More...
|
Argos Therapeutics, Inc. Presents Positive Transplantation and Immunosuppression Data for Soluble CD83 at the American Transplant Congress
6/1/2009 11:28:04 AM
More...
|
REGiMMUNE Presents Enhanced Efficacy Data in Preclinical Transplantation Models at the 2009 American Transplant Congress
6/1/2009 11:12:47 AM
More...
|
Bristol-Myers Squibb Company (BMY) Release: First Phase III Data on Innovative Compound for Solid Organ Transplantation To be Featured at American Transplant Congress
5/28/2009 1:18:23 PM
More...
|
American Transplant Congress 2009: World-Class Speakers Address Congress
5/21/2009 10:59:35 AM
More...
|
|